| Influence of individuals’ determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination ES Chambers, W Cai, G Vivaldi, DA Jolliffe, N Perdek, W Li, SE Faustini, ... npj Vaccines 9 (1), 87, 2024 | | 2024 |
| Prevalence, incidence and determinants of QuantiFERONTM positivity in South African schoolchildren J Stewart, N Walker, K Jennings, C Delport, J Nuttall, AK Coussens, ... IJTLD OPEN 1 (5), 206-214, 2024 | | 2024 |
| Influence of vitamin D supplementation on muscle strength and exercise capacity in Mongolian schoolchildren: a randomised controlled trial D Ganmaa, S Hemmings, DA Jolliffe, U Buyanjargal, G Garmaa, U Adiya, ... MedRxiv, 2024 | 1 | 2024 |
| Influence of vitamin D supplementation on bone mineral content, bone turnover markers, and fracture risk in South African schoolchildren: multicenter double-blind randomized … K Middelkoop, LK Micklesfield, N Walker, J Stewart, C Delport, DA Jolliffe, ... Journal of Bone and Mineral Research 39 (3), 211-221, 2024 | 8 | 2024 |
| Influence of vitamin D supplementation on muscle strength and exercise capacity in South African schoolchildren: a randomised controlled trial (ViDiKids) K Middelkoop, L Micklesfield, S Hemmings, N Walker, J Stewart, D Jolliffe, ... MedRxiv, 2024.03. 26.24304912, 2024 | 1 | 2024 |
| Influence of vitamin D supplementation on growth, body composition, pubertal development and spirometry in South African schoolchildren: a randomised controlled trial (ViDiKids) K Middelkoop, L Micklesfield, J Stewart, N Walker, DA Jolliffe, ... BMJ Paediatrics Open 8 (1), 2024 | 3 | 2024 |
| Influence of age, sex, body habitus, vaccine type and anti-S serostatus on cellular and humoral responses to SARS-CoV-2 vaccination ES Chambers, W Cai, G Vivaldi, DA Jolliffe, N Perdek, W Li, SE Faustini, ... medRxiv, 2023.09. 29.23296222, 2023 | | 2023 |
| Detection of M. tuberculosis DNA in TB contacts’ PBMC does not associate with blood RNA signatures for incipient tuberculosis J Rosenheim, M Abebe, M Belay, B Tulu, D Tayachew, M Tegegn, ... medRxiv, 2023.09. 26.23296131, 2023 | 1 | 2023 |
| Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids) K Middelkoop, J Stewart, N Walker, C Delport, DA Jolliffe, AK Coussens, ... International Journal of Infectious Diseases 134, 63-70, 2023 | 16 | 2023 |
| Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK) F Tydeman, PE Pfeffer, G Vivaldi, H Holt, M Talaei, D Jolliffe, G Davies, ... thorax 78 (8), 752-759, 2023 | 14 | 2023 |
| Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open … DA Jolliffe, AR Martineau LANCET DIABETES & ENDOCRINOLOGY 11 (5), E9-E9, 2023 | | 2023 |
| Correction to Lancet Diabetes Endocrinol DA Jolliffe, AR Martineau | | 2023 |
| Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination H Holt, DA Jolliffe, M Talaei, S Faustini, G Vivaldi, M Greenig, AG Richter, ... npj Vaccines 8 (1), 26, 2023 | 1 | 2023 |
| Analysis of cluster randomised trials as if they were individually randomised–Authors' reply DA Jolliffe, AR Martineau The Lancet Diabetes & Endocrinology 11 (2), 75-76, 2023 | | 2023 |
| Cohort Profile: Longitudinal population-based study of COVID-19 in UK adults (COVIDENCE UK) H Holt, C Relton, M Talaei, J Symons, MR Davies, DA Jolliffe, G Vivaldi, ... International Journal of Epidemiology 52 (1), e46-e56, 2023 | 14 | 2023 |
| Influence of age, sex, body habitus, vaccine type and anti-S serostatus on cellular and humoral responses to SARS-CoV-2 vaccination (preprint) ES Chambers, W Cai, AK Cousens, G Vivaldi, DA Jolliffe, N Perdek, W Li, ... | | 2023 |
| Vitamin D for the management of asthma A Williamson, AR Martineau, A Sheikh, D Jolliffe, CJ Griffiths Cochrane Database of Systematic Reviews, 2023 | 23 | 2023 |
| Correlation between postvaccination anti-spike antibody titers and protection against breakthrough severe acute respiratory syndrome coronavirus 2 infection: a population-based … G Vivaldi, DA Jolliffe, S Faustini, AM Shields, H Holt, N Perdek, M Talaei, ... The Journal of infectious diseases 226 (11), 1903-1908, 2022 | 15 | 2022 |
| S37 Risk factors for breakthrough COVID-19 in 14,713 UK adults after primary and booster doses of SARS-CoV-2 vaccines G Vivaldi, DA Jolliffe, H Holt, M Talaei, F Tydeman, SO Shaheen, ... Thorax 77 (Suppl 1), A25-A26, 2022 | | 2022 |
| S42 Vitamin D to prevent COVID-19 or other acute respiratory infections: phase 3 randomised controlled trial (CORONAVIT) DA Jolliffe, H Holt, M Talaei, A Sheikh, CJ Griffiths, SO Shaheen, C Relton, ... Thorax 77 (Suppl 1), A29-A29, 2022 | | 2022 |
